Ropine Sulfate Injection Usp 0.4 Mg/ml (2017-07-17)

Atropine Sulfate Injection USP 0.4 mg/ml Recall Atropine Sulfate Injection USP 0.4 mg/ml is being recalled in Canada due to product safety concerns. This injectable medication is distributed across Canada. This is a Class I recall, which means the product poses a serious health risk.

Reason

Product safety

Classification

Class I

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2017-10-04

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/7c346ab4-fdb3-4cc1-86cc-9632a5f9fb40